GEN Exclusives

More »

Best Science Apps

More »
Sep 01, 2012 (Vol. 32, No. 15)

Cognitive Consilience

URL:bit.ly/Puw8co
  • Can display individual types of circuits, citations included
  • Users must have some background in neuroanatomy
Platform: iPad/iPhone  
Cost: Free

In the true spirit of consilience (that is, the integration of knowledge), the Cognitive Consilience app brings together myriad studies from the scientific literature to provide users with an integrated overview of the neuroanatomical pathways involved in primate cognition. The home screen of the app displays schematics of five major brain regions involved in cognition—the cerebral cortex, hippocampus, thalamus, basal ganglia, and metencephalon—as well as four additional minor structures (the corpus callosum, spinal cord, claustrum, and basal forebrain). Reported connections between all of these different regions are marked, with citations given at each position. When clicking on the buttons to display the citations, users have the option of opening the citation in PubMed. Users can view all theorized cognitive circuits at once, or they can display one class of circuits at a time—for instance, the circuits believed to be involved in short-term memory, or those involved in information regulation.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?